日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1-3 studies

阿普米司特对银屑病关节炎患者附着点炎和指炎的治疗益处：PALACE 1-3 研究的汇总分析

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2018-000669
Gladman, Dafna D; Kavanaugh, Arthur; Gómez-Reino, Juan J; Wollenhaupt, Jürgen; Cutolo, Maurizio; Schett, Georg; Lespessailles, Eric; Guerette, Benoit; Delev, Nikolay; Teng, Lichen; Edwards, Christopher J; Birbara, Charles A; Mease, Philip J
关节炎
银屑病
发表日期：2018
文献求助 收藏

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis

皮下注射他尼珠单抗治疗膝关节或髋关节骨关节炎患者的安全性和有效性

期刊:Journal of Pain Research
影响因子:2.5
doi:10.2147/JPR.S135257
Birbara, Charles; Dabezies, Eugene J Jr; Burr, Aimee M; Fountaine, Robert J; Smith, Michael D; Brown, Mark T; West, Christine R; Arends, Rosalin H; Verburg, Kenneth M
关节炎
发表日期：2018
文献求助 收藏

3D printing from cardiovascular CT: a practical guide and review

基于心血管CT的3D打印：实用指南与综述

期刊:Cardiovascular Diagnosis and Therapy
影响因子:2.1
doi:10.21037/cdt.2017.01.12
Otton, James M; Birbara, Nicolette S; Hussain, Tarique; Greil, Gerald; Foley, Thomas A; Pather, Nalini
3D/类器官
发表日期：2017
文献求助 收藏

Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)

阿普米司特（一种口服磷酸二酯酶 4 抑制剂）治疗银屑病关节炎伴当前皮肤受累患者：一项 III 期随机对照试验 (PALACE 3)

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2015-207963
Edwards, Christopher J; Blanco, Francisco J; Crowley, Jeffrey; Birbara, Charles A; Jaworski, Janusz; Aelion, Jacob; Stevens, Randall M; Vessey, Adele; Zhan, Xiaojiang; Bird, Paul
关节炎
银屑病
发表日期：2016
文献求助 收藏

Tanezumab for the treatment of pain from osteoarthritis of the knee

Tanezumab 用于治疗膝关节骨关节炎疼痛

期刊:New England Journal of Medicine
影响因子:78.5
doi:10.1056/NEJMoa0901510
Lane, Nancy E; Schnitzer, Thomas J; Birbara, Charles A; Mokhtarani, Masoud; Shelton, David L; Smith, Mike D; Brown, Mark T
关节炎
发表日期：2010
文献求助 收藏

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

阿达木单抗用于银屑病关节炎的长期治疗：来自阿达木单抗治疗银屑病关节炎疗效试验（ADEPT）的 2 年数据

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2008.092767
Mease, P J; Ory, P; Sharp, J T; Ritchlin, C T; Van den Bosch, F; Wellborne, F; Birbara, C; Thomson, G T D; Perdok, R J; Medich, J; Wong, R L; Gladman, D D
关节炎
银屑病
发表日期：2009
文献求助 收藏

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

英夫利昔单抗治疗活动性银屑病关节炎患者1年后仍能维持较高的临床疗效：IMPACT 2试验结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2006.058339
Kavanaugh, A; Krueger, G G; Beutler, A; Guzzo, C; Zhou, B; Dooley, L T; Mease, P J; Gladman, D D; de Vlam, K; Geusens, P P; Birbara, C; Halter, D G; Antoni, C
关节炎
银屑病
发表日期：2007
文献求助 收藏

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

英夫利昔单抗可改善银屑病关节炎的体征和症状：IMPACT 2 试验结果

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/ard.2004.032268
Antoni, C; Krueger, G G; de Vlam, K; Birbara, C; Beutler, A; Guzzo, C; Zhou, B; Dooley, L T; Kavanaugh, A
关节炎
银屑病
发表日期：2005
文献求助 收藏

Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis

英夫利昔单抗剂量上调在类风湿性关节炎管理式医疗患者中的发生频率、预测因素和经济影响

期刊:Journal of Managed Care Pharmacy
影响因子:
doi:10.18553/jmcp.2005.11.5.383
Ollendorf, Daniel A; Massarotti, Elena; Birbara, Charles; Burgess, Somali Misra
关节炎
发表日期：2005
文献求助 收藏